- Home
- MEDP vs WPC Comparison
MEDP vs WPC Comparison
Compare MEDP & WPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- WPC
- Stock Information
- Founded
- MEDP 1992
- WPC 1973
- Country
- MEDP United States
- WPC United States
- Employees
- MEDP N/A
- WPC N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- WPC Real Estate Investment Trusts
- Sector
- MEDP Health Care
- WPC Real Estate
- Exchange
- MEDP Nasdaq
- WPC Nasdaq
- Market Cap
- MEDP 11.7B
- WPC 13.2B
- IPO Year
- MEDP 2016
- WPC 1998
- Fundamental
- Price
- MEDP $342.89
- WPC $59.31
- Analyst Decision
- MEDP Buy
- WPC Hold
- Analyst Count
- MEDP 10
- WPC 11
- Target Price
- MEDP $402.44
- WPC $62.33
- AVG Volume (30 Days)
- MEDP 385.5K
- WPC 1.1M
- Earning Date
- MEDP 10-21-2024
- WPC 10-29-2024
- Dividend Yield
- MEDP N/A
- WPC 5.90%
- EPS Growth
- MEDP 27.33
- WPC N/A
- EPS
- MEDP 10.64
- WPC 2.61
- Revenue
- MEDP $2,030,048,000.00
- WPC $1,643,457,000.00
- Revenue This Year
- MEDP $15.81
- WPC N/A
- Revenue Next Year
- MEDP $12.91
- WPC $5.77
- P/E Ratio
- MEDP $32.21
- WPC $22.74
- Revenue Growth
- MEDP 21.36
- WPC N/A
- 52 Week Low
- MEDP $227.21
- WPC $50.54
- 52 Week High
- MEDP $459.77
- WPC $67.40
- Technical
- Relative Strength Index (RSI)
- MEDP 46.60
- WPC 38.70
- Support Level
- MEDP $331.32
- WPC $58.91
- Resistance Level
- MEDP $357.10
- WPC $60.39
- Average True Range (ATR)
- MEDP 8.70
- WPC 0.86
- MACD
- MEDP 2.17
- WPC -0.25
- Stochastic Oscillator
- MEDP 58.00
- WPC 11.25
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About WPC W. P. Carey Inc. REIT
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. most of the company's revenue comes from properties in the USA. The company's Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.